KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to -$107.8 million.

  • Hims & Hers Health's Cash from Financing Activities fell 0.49% to -$39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.5 million, marking a year-over-year increase of 928.77%. This contributed to the annual value of -$107.8 million for FY2024, which is 839.83% down from last year.
  • Latest data reveals that Hims & Hers Health reported Cash from Financing Activities of -$107.8 million as of FY2024, which was down 839.83% from -$11.5 million recorded in FY2023.
  • Hims & Hers Health's Cash from Financing Activities' 5-year high stood at $235.0 million during FY2021, with a 5-year trough of -$107.8 million in FY2024.
  • For the 3-year period, Hims & Hers Health's Cash from Financing Activities averaged around -$50.8 million, with its median value being -$33.1 million (2022).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 392.32% in 2021, then plummeted by 839.83% in 2024.
  • Over the past 5 years, Hims & Hers Health's Cash from Financing Activities (Yearly) stood at $47.7 million in 2020, then spiked by 392.32% to $235.0 million in 2021, then slumped by 114.09% to -$33.1 million in 2022, then soared by 65.36% to -$11.5 million in 2023, then crashed by 839.83% to -$107.8 million in 2024.